Financhill
Sell
49

KDDIY Quote, Financials, Valuation and Earnings

Last price:
$18.08
Seasonality move :
5.89%
Day range:
$17.40 - $18.19
52-week range:
$9.06 - $18.50
Dividend yield:
2.53%
P/E ratio:
17.10x
P/S ratio:
1.87x
P/B ratio:
2.19x
Volume:
203.1K
Avg. volume:
415.4K
1-year change:
25.23%
Market cap:
$71.5B
Revenue:
$39.9B
EPS (TTM):
$1.05
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $48.2B $50.1B $48.5B $42B $39.9B
Revenue Growth (YoY) 5.15% 4% -3.19% -13.43% -5.07%
 
Cost of Revenues $26.9B $27.6B $26.6B $24.1B $23B
Gross Profit $21.3B $22.5B $21.9B $17.9B $16.8B
Gross Profit Margin 44.15% 44.88% 45.2% 42.52% 42.24%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12B $12.9B $12.7B $10.4B $10.4B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $11.9B $12.8B $12.5B $9.9B $10.2B
Operating Income $9.4B $9.7B $9.4B $7.9B $6.6B
 
Net Interest Expenses $55.7M $16.7M -- -- --
EBT. Incl. Unusual Items $9.4B $9.8B $9.5B $8B $6.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3B $3.1B $3B $2.5B $2.3B
Net Income to Company $9.4B $9.8B $9.5B $8B $6.9B
 
Minority Interest in Earnings -$511.9M -$519.9M -$534.9M -$451.2M -$126.3M
Net Income to Common Excl Extra Items $5.9B $6.1B $6B $5B $4.4B
 
Basic EPS (Cont. Ops) $1.27 $1.34 $1.34 $1.15 $1.04
Diluted EPS (Cont. Ops) $1.27 $1.34 $1.33 $1.15 $1.04
Weighted Average Basic Share $4.6B $4.6B $4.5B $4.4B $4.2B
Weighted Average Diluted Share $4.6B $4.6B $4.5B $4.4B $4.2B
 
EBITDA $15.8B $16.7B $16B $13.2B $11.7B
EBIT $9.5B $9.9B $9.6B $8.1B $7B
 
Revenue (Reported) $48.2B $50.1B $48.5B $42B $39.9B
Operating Income (Reported) $9.4B $9.7B $9.4B $7.9B $6.6B
Operating Income (Adjusted) $9.5B $9.9B $9.6B $8.1B $7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $13.3B $12.2B $10.2B $10.1B $9.9B
Revenue Growth (YoY) 7.89% -7.99% -16.27% -1.57% 1.84%
 
Cost of Revenues $7.3B $6.6B $5.9B $5.8B $5.7B
Gross Profit $6B $5.7B $4.3B $4.3B $4.2B
Gross Profit Margin 44.91% 46.28% 42.13% 42.26% 42.13%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3B $3B $2.4B $2.3B $2.3B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.3B $3B $2.3B $2.3B $2.3B
Operating Income $2.7B $2.6B $2B $1.9B $1.8B
 
Net Interest Expenses $7M -- $20.2M $18.6M --
EBT. Incl. Unusual Items $2.7B $2.7B $2B $1.9B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $839.6M $850.5M $645.2M $618.8M $609.7M
Net Income to Company $2.8B $2.5B $1.9B $1.9B --
 
Minority Interest in Earnings -$180.7M -$122M -$92.8M -$121.7M -$117.7M
Net Income to Common Excl Extra Items $1.7B $1.7B $1.3B $1.2B $1.2B
 
Basic EPS (Cont. Ops) $0.37 $0.38 $0.29 $0.29 $0.30
Diluted EPS (Cont. Ops) $0.37 $0.38 $0.29 $0.29 $0.30
Weighted Average Basic Share $4.6B $4.5B $4.4B $4.2B $4B
Weighted Average Diluted Share $4.6B $4.5B $4.4B $4.2B $4B
 
EBITDA $4.5B $4.2B $3.3B $3.1B $3.1B
EBIT $2.7B $2.7B $2B $2B $1.9B
 
Revenue (Reported) $13.3B $12.2B $10.2B $10.1B $9.9B
Operating Income (Reported) $2.7B $2.6B $2B $1.9B $1.8B
Operating Income (Adjusted) $2.7B $2.7B $2B $2B $1.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $49.3B $49.2B $43.1B $41.1B $40B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $27B $27.1B $24.7B $23.7B $23.3B
Gross Profit $22.3B $22.2B $18.3B $17.3B $16.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12.6B $12.8B $11B $10B $10.2B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $12.4B $12.8B $10.6B $9.7B $10.1B
Operating Income $9.8B $9.4B $7.8B $7.6B $6.5B
 
Net Interest Expenses $39.7M -- $2.3M -- --
EBT. Incl. Unusual Items $9.9B $9.5B $7.8B $7.9B $6.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.1B $3.1B $2.4B $2.4B $2.3B
Net Income to Company $10B $9.2B $7.7B $7.9B --
 
Minority Interest in Earnings -$562.1M -$461.1M -$448.1M -$518.5M -$149M
Net Income to Common Excl Extra Items $6.2B $6B $4.9B $4.9B $4.4B
 
Basic EPS (Cont. Ops) $1.35 $1.32 $1.13 $1.15 $1.05
Diluted EPS (Cont. Ops) $1.34 $1.32 $1.13 $1.15 $1.05
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $16.6B $16.3B $13.3B $12.9B $11.6B
EBIT $10B $9.6B $7.9B $8B $6.9B
 
Revenue (Reported) $49.3B $49.2B $43.1B $41.1B $40B
Operating Income (Reported) $9.8B $9.4B $7.8B $7.6B $6.5B
Operating Income (Adjusted) $10B $9.6B $7.9B $8B $6.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $36.1B $30.7B $29.8B $18.8B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $19.1B $17.2B $16.9B $10.6B --
Gross Profit $17.1B $13.5B $12.9B $8.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.3B $7.6B $7.2B $4.6B --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $9.2B $7.3B $7B $4.6B --
Operating Income $7.8B $6.2B $5.9B $3.6B --
 
Net Interest Expenses $6.1M $36M $18.6M -- --
EBT. Incl. Unusual Items $7.9B $6.2B $6.1B $3.8B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.5B $2B $1.9B $1.2B --
Net Income to Company $7.7B $6B $5.9B -- --
 
Minority Interest in Earnings -$415.9M -$328.1M -$392.8M -$241.2M --
Net Income to Common Excl Extra Items $5B $3.9B $3.8B $2.4B --
 
Basic EPS (Cont. Ops) $1.11 $0.90 $0.90 $0.58 --
Diluted EPS (Cont. Ops) $1.11 $0.90 $0.90 $0.58 --
Weighted Average Basic Share $13.5B $13.1B $12.8B $8.2B --
Weighted Average Diluted Share $13.5B $13.2B $12.8B $8.2B --
 
EBITDA $12.9B $10.1B $9.7B $6B --
EBIT $8B $6.3B $6.1B $3.8B --
 
Revenue (Reported) $36.1B $30.7B $29.8B $18.8B --
Operating Income (Reported) $7.8B $6.2B $5.9B $3.6B --
Operating Income (Adjusted) $8B $6.3B $6.1B $3.8B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $3.4B $7.3B $6.5B $3.6B $5.9B
Short Term Investments $2.5B $2.8B $2.6B $2.7B $2.6B
Accounts Receivable, Net $20.1B $20.2B $18.9B $18.4B $17.9B
Inventory $697.4M $632.9M $610.5M $743.3M $603.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $782.8M $947.2M $932.5M $1.1B $939.9M
Total Current Assets $28B $32.3B $30B $26.9B $28.1B
 
Property Plant And Equipment $25.8B $26.2B $24.4B $22.4B $21.2B
Long-Term Investments -- -- -- -- --
Goodwill $5B $4.9B $4.4B $4.1B $3.8B
Other Intangibles $9.6B $9.3B $8.4B $7.9B $7B
Other Long-Term Assets $147.8M $193.3M $205.5M $224.6M $242.3M
Total Assets $88.6B $95.5B $90.8B $89.5B $93.5B
 
Accounts Payable $6.1B $6.8B $6.8B $6B $5.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1B $1B $923.5M $846.6M $779.7M
Other Current Liabilities $15.6B $19B $19.7B $21.7B $26.2B
Total Current Liabilities $27.9B $31.9B $32.9B $34.8B $39.4B
 
Long-Term Debt $10.6B $10.4B $7.6B $6.9B $10.4B
Capital Leases -- -- -- -- --
Total Liabilities $43.7B $47.8B $45.7B $46.9B $55.2B
 
Common Stock $1.3B $1.3B $1.2B $1.1B $937.2M
Other Common Equity Adj -- -- -- -- --
Common Equity $40.6B $43.1B $40.8B $38.5B $34.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4.4B $4.5B $4.3B $4.1B $3.6B
Total Equity $45B $47.7B $45.1B $42.6B $38.3B
 
Total Liabilities and Equity $88.6B $95.5B $90.8B $89.5B $93.5B
Cash and Short Terms $5.9B $10.1B $9.2B $6.3B $8.5B
Total Debt $12.7B $12.3B $11.1B $9.4B $13.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.1B $4.5B $4.2B $4.4B $5.5B
Short Term Investments $2.9B $2.8B $2.7B $2.8B $220.9M
Accounts Receivable, Net $21.1B $19.6B $17.9B $18.3B $18.3B
Inventory $805.1M $775.3M $852.4M $883.9M $833.3M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $1.1B $1.2B $1.3B $1.8B
Total Current Assets $30.5B $29.1B $27.7B $28.2B $30.8B
 
Property Plant And Equipment $27.7B $25.5B $22.5B $22.4B $20.9B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $4.7B $4.1B $4.1B $3.7B
Other Intangibles $9.8B $8.8B $7.9B $7.4B $6.6B
Other Long-Term Assets $178.8M $188.8M $210.5M $223.1M $246.4M
Total Assets $98.5B $94.2B $88.6B $95.4B $103.7B
 
Accounts Payable $6.2B $6B $6B $5.7B $5.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.1B $946.6M $833.7M $793.2M $685.8M
Other Current Liabilities $19.7B $20.1B $21.3B $23.7B $27.9B
Total Current Liabilities $31.5B $32.3B $34.8B $36.9B $47.5B
 
Long-Term Debt $11.5B $9.2B $6.5B $11.9B $14.4B
Capital Leases -- -- -- -- --
Total Liabilities $49B $47.1B $46.4B $54.5B $67.5B
 
Common Stock $1.4B $1.2B $1.1B $1B $903.3M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4.7B $4.5B $4B $4.3B $3.5B
Total Equity $49.5B $47.1B $42.2B $40.9B $36.2B
 
Total Liabilities and Equity $98.5B $94.2B $88.6B $95.4B $103.7B
Cash and Short Terms $7.1B $7.3B $6.9B $7.3B $5.7B
Total Debt $13.4B $12.9B $10.3B $15.1B $24.4B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $9.4B $9.8B $9.5B $8B $6.9B
Depreciation & Amoritzation $6.3B $6.9B $6.5B $5.2B $4.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$5.8B -$2.3B -$2.4B -$6.5B -$7.1B
Change in Inventories $138.6M $51.8M -$40.8M -$180.9M $52.9M
Cash From Operations $12.2B $15.9B $13.1B $8B $11.8B
 
Capital Expenditures $5.7B $5.9B $6B $4.7B $5.2B
Cash Acquisitions -$110.1M $6.8M -$74.6M -$72.9M $155.4M
Cash From Investing -$5.6B -$6.2B -$6.8B -$5.4B -$5.8B
 
Dividends Paid (Ex Special Dividend) -$2.4B -$2.6B -$2.4B -$2.1B -$2.1B
Special Dividend Paid
Long-Term Debt Issued $1.7B $731.1M -- $1.5B $2.9B
Long-Term Debt Repaid -$1.1B -$1.4B -$653.6M -$1.5B -$1.5B
Repurchase of Common Stock -$1.4B -$1.3B -$1.9B -$1.9B -$2.1B
Other Financing Activities -$78.1M -$45.4M -$51.3M -$51.5M $5.3M
Cash From Financing -$5B -$5.5B -$6.5B -$5B -$3.3B
 
Beginning Cash (CF) $1.9B $3.5B $7.2B $5.9B $3.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B $4.1B -$180M -$2.4B $2.8B
Ending Cash (CF) $3.4B $7.6B $7.1B $3.6B $6.1B
 
Levered Free Cash Flow $6.5B $10B $7.1B $3.3B $6.6B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $1.7B $1.5B $1.8B $2B $990.7M
Depreciation & Amoritzation $1.6B $1.8B $1.7B $1.5B $1.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.8B $1B $1.2B -$2.4B -$3.9B
Change in Inventories $98.7M $126.3M $130M $84.4M $225.5M
Cash From Operations $4.3B $5.8B $6.6B $2B $4.6B
 
Capital Expenditures $1.6B $1.6B $1.4B $1.4B $1.3B
Cash Acquisitions -$55M -$20.1M -$10.3M -$20.7M $16.2M
Cash From Investing -$1.7B -$1.6B -$1.7B -$1.4B -$1.2B
 
Dividends Paid (Ex Special Dividend) -$10.8M $37.8M -$31.1M -$90.8M -$47.8M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $788.9K -$11M -- $771.8M $268.6M
Long-Term Debt Repaid -$16.2M $6.7M -$286.7M -$818.1M -$337.4M
Repurchase of Common Stock -$657.4K -$679.9M -$506.2M -$382M -$260.3M
Other Financing Activities -$59.9M -$15.2M -$79.4M -$27.3M -$16.6M
Cash From Financing -$2.4B -$694.7M -$2.5B -$1.2B -$1.6B
 
Beginning Cash (CF) $3.2B $4.1B $4.6B $3.9B $4.2B
Foreign Exchange Rate Adjustment -$9.8M $36.1M $40.2M $8.3M $33.5M
Additions / Reductions $188.6M $3.6B $2.4B -$618.6M $1.8B
Ending Cash (CF) $3.4B $7.6B $7.1B $3.6B $6.1B
 
Levered Free Cash Flow $2.7B $4.3B $5.2B $581.8M $3.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $10B $9.2B $7.7B $7.9B --
Depreciation & Amoritzation $6.7B $6.6B $5.4B $4.9B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$5.1B -$2.6B -$2.9B -$5.6B --
Change in Inventories $24.1M -$44.5M -$135.2M -$88.2M --
Cash From Operations $14.4B $12.3B $12.6B $9.2B --
 
Capital Expenditures $5.9B $6.2B $4.6B $5.3B $4.2B
Cash Acquisitions -$28.1M -$84.4M -$62.5M $118.5M $204M
Cash From Investing -$6.4B -$6.6B -$5.8B -$6B --
 
Dividends Paid (Ex Special Dividend) -$2.7B -$2.3B -$2.1B -$2.1B -$969.5M
Special Dividend Paid
Long-Term Debt Issued -- -- $709.3M $3.4B --
Long-Term Debt Repaid -$1.5B -$360.2M -$953.5M -$2B --
Repurchase of Common Stock -- -$2.1B -$2B -$2.2B --
Other Financing Activities -$90.1M $12.8M -$103.5M -$5.5M --
Cash From Financing -$7.2B -$4.7B -$6.2B -$2.9B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $752.6M $1B $596M $320.2M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $8.5B $6.1B $7.9B $3.9B --
Period Ending 2021-05-07 2022-05-07 2023-05-07 2024-05-07
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock